Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
2,029
+1
+0% +$117 0.09% 174
2026
Q1
$244K Buy
2,028
+2
+0.1% +$231 0.1% 162
2025
Q4
$213K Buy
+2,026
New +$190K 0.09% 175
2024
Q4
– Sell
-2,007
Closed -$228K – 167
2024
Q3
$228K Sell
2,007
-48
-2% -$5.7K 0.12% 156
2024
Q2
$254K Buy
+2,055
New +$265K 0.14% 138

Other funds holding MRK

Creekside Partners's MRK Position: Q2 2026 in Review

Creekside Partners increased its Merck (MRK) stake by 0.05% in Q2 2026, buying an estimated $117 and bringing the position to 2,029 shares worth $261K. The position accounts for 0.09% of the portfolio, ranked #174.

Creekside Partners first reported a position in MRK in Q2 2024 and has held it in 5 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Creekside Partners held 2,029 shares of Merck worth $261K as of Q2 2026.
  • Creekside Partners bought 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.09% of Creekside Partners's portfolio in Q2 2026, its #174 holding.
  • Creekside Partners first reported a position in Merck in Q2 2024 and has held it in 5 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Creekside Partners's 13F filing for Q2 2026, filed 31 Jul 2026.